Literature DB >> 11118260

Herpes simplex encephalitis: involvement of apolipoprotein E genotype.

W R Lin1, M A Wozniak, M M Esiri, P Klenerman, R F Itzhaki.   

Abstract

It was previously found that herpes simplex type 1 virus (HSV1) when present in the brain, is a risk factor for Alzheimer's disease in carriers of the type 4 allele of the gene for apolipoprotein E (apoE epsilon4), and apoE epsilon4 is a risk factor for herpes labialis. Whether a specific allele of the gene is involved in susceptibility to another disorder caused by HSV1-herpes simplex encephalitis (HSE)-has now been investigated. DNA was prepared from formalin-fixed, paraffin-embedded blocks of specimens from the brain or spleen of 14 United Kingdom patients with HSE, confirmed by necropsy, and from the CSF of seven United Kingdom clinical patients with HSV1 in their CSF detected by polymerase chain reaction (PCR). ApoE genotype of the DNA from blocks was determined by seminested PCR, and of the DNA from CSF by one step PCR, followed by restriction endonuclease digestion. The apoE allele frequencies were compared with values previously obtained for 238 normal people from the United Kingdom. The apoE epsilon2 allele frequency of the patients with HSE was 26%, significantly higher than the value of 7% for the normal subjects (OR=4.6, 95% confidence interval (95% CI) 2. 0-10.8). The apoE epsilon3 and epsilon4 allele frequencies did not differ significantly between the two groups. Thus, it seems that apoE epsilon2 is a risk factor for HSE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11118260      PMCID: PMC1763452          DOI: 10.1136/jnnp.70.1.117

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  13 in total

1.  Association of HSV1 and apolipoprotein E-varepsilon4 in Alzheimer's disease.

Authors:  R F Itzhaki; C B Dobson; W R Lin; M A Wozniak
Journal:  J Neurovirol       Date:  2001-12       Impact factor: 2.643

2.  Alzheimer's disease and herpes.

Authors:  Ruth F Itzhaki; Curtis B Dobson
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

3.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

Review 4.  Apolipoprotein E alleles can contribute to the pathogenesis of numerous clinical conditions including HSV-1 corneal disease.

Authors:  James M Hill; Partha S Bhattacharjee; Donna M Neumann
Journal:  Exp Eye Res       Date:  2006-09-26       Impact factor: 3.467

5.  Association between Apolipoprotein E genotype and cerebral palsy is not confirmed in a Caucasian population.

Authors:  Gai L McMichael; Catherine S Gibson; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker; Alastair H MacLennan
Journal:  Hum Genet       Date:  2008-09-23       Impact factor: 4.132

Review 6.  Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  Clive Holmes; Darren Cotterell
Journal:  CNS Drugs       Date:  2009-12       Impact factor: 5.749

7.  HSV, axonal transport and Alzheimer's disease: in vitro and in vivo evidence for causal relationships.

Authors:  Elaine L Bearer
Journal:  Future Virol       Date:  2012-09       Impact factor: 1.831

8.  Association of apolipoprotein E with the progression of hepatitis B virus-related liver disease.

Authors:  Yueshuang Shen; Meng Li; Xiongwei Ye; Qihua Bi
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

9.  Alzheimer's Disease: APP, Gamma Secretase, APOE, CLU, CR1, PICALM, ABCA7, BIN1, CD2AP, CD33, EPHA1, and MS4A2, and Their Relationships with Herpes Simplex, C. Pneumoniae, Other Suspect Pathogens, and the Immune System.

Authors:  Chris Carter
Journal:  Int J Alzheimers Dis       Date:  2011-12-29

10.  Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.

Authors:  Amber Watts; Eileen M Crimmins; Margaret Gatz
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.